Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Cytotherapy|September 9, 2005
Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potentialT Tondreau, L Lagneaux, M Dejeneffe, et al.
Blood Cells|January 1, 1982
Scientific basis and criticism of current therapy of acute leukemiaP Stryckmans, A Delforge, D Bron, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
Journal of Hematotherapy|April 1, 1997
Ex vivo expansion of CD34 + CD38- cord blood cellsC De Bruyn, A Delforge, D Bron, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugsP Dodion, D Bron, M A Mattelaer, et al.
Stem Cells (Dayton, Ohio)|May 1, 1995
Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrowC De Bruyn, A Delforge, D Bron, et al.
Presse Medicale (Paris, France : 1983)|June 10, 1989
[Adoptive immunotherapy with interleukin 2. Initial results of a pilot study in 6 cancer patients]J P Sculier, D Bron, A Delforge, et al.
Leukemia & Lymphoma|July 29, 2016
Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid MalignanciesA Delforge, M Bernier, E Bosmans, et al.
Leukemia & Lymphoma|August 26, 1998
Myeloid and lymphoid recovery following allogeneic bone marrow transplantation: a comparative study between related, unrelated bone marrow and allogeneic peripheral stem cell transplantationR Trenschel, M Bernier, A Delforge, et al.
Journal of the National Cancer Institute|April 1, 1981
Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agentT E Spiro, M Socquet, A Delforge, et al.
Pageof 17